BMEMat Биоматериалы

Defect‐engineered tungsten oxide nanowires as redox‐metabolic nanozymes for gut inflammation‐infection syndromes

Yifan Yuan, Shipeng Zhang, Mingxuan Liu, Xurui Hou, Yizhi Dai, Weiyu Zhang, Zhongwei Yang, Xiaoyu Zhang, Jiahui Mao, Mingge Wang, Xin Yang, Ping Zhang, Hui Wang, Jing Liu
Wiley · 2026-10-08 · DOI 10.1002/bmm2.70142

Аннотация

Abstract Inflammatory bowel disease (IBD) complicated by Salmonella infection features a coupled inflammation‐infection pathology driven by oxidative/nitrosative stress, barrier disruption, and microbiome imbalance. Here we report defect‐engineered tungsten oxide (WO 3 ) nanowires as a multifunctional nanozyme platform that integrates redox regulation, pathogen metabolic suppression, and mucosal repair. Defect programming generates abundant oxygen vacancies together with mixed‐valence W 4+ /W 5+ /W 6+ sites, which markedly enhances the catalytic scavenging of reactive oxygen and nitrogen species (reactive oxygen species/reactive nitrogen species) and enables effective control of intestinal redox stress. In parallel, WO 4 2− released from the nanowires competitively interfere with molybdate‐dependent nitrate reductase activity in Salmonella , thereby impairing nitrate respiration and ATP production to attenuate pathogen fitness. In vitro, the defect‐engineered WO 3 nanozymes protect intestinal epithelial cells from oxidative injury and inhibit Salmonella growth. In a DSS‐induced colitis model with Salmonella co‐infection, oral administration significantly alleviated inflammation, restored epithelial integrity, and rebalanced immune and microbial homeostasis. These results establish a defect‐guided redox‐metabolic therapeutic paradigm for addressing inflammation–infection interplay in the gut, and highlight defect‐engineered WO 3 nanowires as a promising chemical platform for complex intestinal disorders.

Читать у издателя →